TFC Financial Management’s Foghorn Therapeutics FHTX Stock Holding History

TFC Financial Management’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$588	Hold	123	–	–	﹤0.01%	682
2025 Q4	$665	Hold	123	–	–	﹤0.01%	658
2025 Q3	$602	Hold	123	–	–	﹤0.01%	689
2025 Q2	$579	Hold	123	–	–	﹤0.01%	654
2025 Q1	$449	Hold	123	–	–	﹤0.01%	663
2024 Q4	$581	Hold	123	–	–	﹤0.01%	635
2024 Q3	$1.15K	Hold	123	–	–	﹤0.01%	574
2024 Q2	$708	Hold	123	–	–	﹤0.01%	597
2024 Q1	$826	Hold	123	–	–	﹤0.01%	573
2023 Q4	$794	Hold	123	–	–	﹤0.01%	544
2023 Q3	$615	Buy	+123	New	+$948	﹤0.01%	583
2021 Q2	–	Sell	-280	Closed	-$4K	–	584
2021 Q1	$4K	Hold	280	–	–	﹤0.01%	379
2020 Q4	$6K	Buy	+280	New	+$5.36K	﹤0.01%	342

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

TFC Financial Management's FHTX Position: Q1 2026 in Review

TFC Financial Management held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 123 shares worth $588. The position accounts for ﹤0.01% of the portfolio, ranked #682.

TFC Financial Management first reported a position in FHTX in Q4 2020 and has held it in 13 quarters since. The position peaked at $6K in Q4 2020. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

TFC Financial Management held 123 shares of Foghorn Therapeutics worth $588 as of Q1 2026.
TFC Financial Management left its Foghorn Therapeutics share count unchanged in Q1 2026.
Foghorn Therapeutics made up ﹤0.01% of TFC Financial Management's portfolio in Q1 2026, its #682 holding.
TFC Financial Management first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 13 quarters since.
TFC Financial Management's Foghorn Therapeutics position peaked at $6K in Q4 2020.
105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on TFC Financial Management's 13F filing for Q1 2026, filed 23 Apr 2026.